Paper277243
Sensitization of mouse tumours using fractionated X-irradiation.
Denekamp J and 1 other. Br J Cancer Suppl, 1978. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Sensitization of mouse tumours using fractionated X-irradiation. Papers, record 277243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/277243
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms, Experimental | Major topic |
| Nitroimidazoles | Major topic |
| Radiation-Sensitizing Agents | Major topic |
| Animals | |
| Mice | |
| Oxygen | |
| Radiotherapy Dosage |
Source PubMed
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 277239 | Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour. | Br J Cancer Suppl | 1978 | https://conductscience.org/library/papers/277239 | PubMed |
| 2 | 870132 | Tumour regression as a guide to prognosis: a study with experimental animals. | Br J Radiol | 1977 | https://conductscience.org/library/papers/870132 | PubMed |
| 3 | 993090 | Metronidazole and fractionated radiotherapy of a murine tumor. | Int J Radiat Oncol Biol Phys | 1976 | https://conductscience.org/library/papers/993090 | PubMed |
| 4 | 977399 | Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons. | Int J Radiat Oncol Biol Phys | 1976 | https://conductscience.org/library/papers/977399 | PubMed |
| 5 | 5074775 | The relationship between the 'cell loss factor' and the immediate response to radiation in animal tumours. | Eur J Cancer (1965) | 1972 | https://conductscience.org/library/papers/5074775 | PubMed |
| 6 | 4996862 | The oxygen effect and radiotherapy with fast neutrons. | Eur J Cancer (1965) | 1971 | https://conductscience.org/library/papers/4996862 | PubMed |
| 7 | 1257411 | The response of a transplantable tumor to fractionated irradiation. 1. X rays and the hypoxic cell radiosensitizer Ro-07-0582. | Radiat Res | 1976 | https://conductscience.org/library/papers/1257411 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7362769 | Is tumour radiosensitization by misonidazole a general phenomenon? | Br J Cancer | 1980 | https://conductscience.org/library/papers/7362769 | PubMed |
| 6487517 | Chemopotentiation in vivo: no loss of sensitization with fractionation. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6487517 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/277243
GET https://conductscience.org/api/papers/v1/277243/authors